Literature DB >> 32847824

From pluripotency to totipotency: an experimentalist's guide to cellular potency.

Alba Redó Riveiro1, Joshua Mark Brickman2.   

Abstract

Embryonic stem cells (ESCs) are derived from the pre-implantation mammalian blastocyst. At this point in time, the newly formed embryo is concerned with the generation and expansion of both the embryonic lineages required to build the embryo and the extra-embryonic lineages that support development. When used in grafting experiments, embryonic cells from early developmental stages can contribute to both embryonic and extra-embryonic lineages, but it is generally accepted that ESCs can give rise to only embryonic lineages. As a result, they are referred to as pluripotent, rather than totipotent. Here, we consider the experimental potential of various ESC populations and a number of recently identified in vitro culture systems producing states beyond pluripotency and reminiscent of those observed during pre-implantation development. We also consider the nature of totipotency and the extent to which cell populations in these culture systems exhibit this property.
© 2020. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Developmental biology; Pluripotency; Totipotency

Mesh:

Year:  2020        PMID: 32847824     DOI: 10.1242/dev.189845

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  8 in total

1.  Identification of the central intermediate in the extra-embryonic to embryonic endoderm transition through single-cell transcriptomics.

Authors:  Michaela Mrugala Rothová; Alexander Valentin Nielsen; Martin Proks; Yan Fung Wong; Alba Redo Riveiro; Madeleine Linneberg-Agerholm; Eyal David; Ido Amit; Ala Trusina; Joshua Mark Brickman
Journal:  Nat Cell Biol       Date:  2022-06-09       Impact factor: 28.213

2.  Pursuing totipotency: authentic totipotent stem cells in culture.

Authors:  Vikas Malik; Jianlong Wang
Journal:  Trends Genet       Date:  2022-04-18       Impact factor: 11.821

3.  Excavating the pathogenic gene of breast cancer based on high throughput data of tumor and somatic reprogramming.

Authors:  Lian Duan; Zhendong Wang; Xin Zheng; Junjian Li; Huamin Yin; Weibo Tang; Dejian Deng; Hui Liu; Jiayu Wei; Yan Jin; Feng Liu; Jingling Shen
Journal:  Cell Cycle       Date:  2021-08-13       Impact factor: 5.173

Review 4.  From Snapshots to Development: Identifying the Gaps in the Development of Stem Cell-based Embryo Models along the Embryonic Timeline.

Authors:  Vinidhra Shankar; Clemens van Blitterswijk; Erik Vrij; Stefan Giselbrecht
Journal:  Adv Sci (Weinh)       Date:  2021-03-02       Impact factor: 16.806

5.  CTCF is a barrier for 2C-like reprogramming.

Authors:  Teresa Olbrich; Maria Vega-Sendino; Desiree Tillo; Wei Wu; Nicholas Zolnerowich; Raphael Pavani; Andy D Tran; Catherine N Domingo; Mariajose Franco; Marta Markiewicz-Potoczny; Gianluca Pegoraro; Peter C FitzGerald; Michael J Kruhlak; Eros Lazzerini-Denchi; Elphege P Nora; André Nussenzweig; Sergio Ruiz
Journal:  Nat Commun       Date:  2021-08-11       Impact factor: 14.919

Review 6.  Somatic Reprogramming-Above and Beyond Pluripotency.

Authors:  Yaa-Jyuhn James Meir; Guigang Li
Journal:  Cells       Date:  2021-10-26       Impact factor: 6.600

7.  Transcriptional heterogeneity and cell cycle regulation as central determinants of Primitive Endoderm priming.

Authors:  Marta Perera; Silas Boye Nissen; Martin Proks; Sara Pozzi; Rita S Monteiro; Ala Trusina; Joshua M Brickman
Journal:  Elife       Date:  2022-08-15       Impact factor: 8.713

8.  Metabolic control of histone acetylation for precise and timely regulation of minor ZGA in early mammalian embryos.

Authors:  Jingyu Li; Jiaming Zhang; Weibo Hou; Xu Yang; Xiaoyu Liu; Yan Zhang; Meiling Gao; Ming Zong; Zhixiong Dong; Zhonghua Liu; Jingling Shen; Weitao Cong; Chunming Ding; Shaorong Gao; Guoning Huang; Qingran Kong
Journal:  Cell Discov       Date:  2022-09-27       Impact factor: 38.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.